President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
Heading into 2022, the eyes of political nerds like us are fixed on statehouses across the country. State legislatures are in the process of taking the data from the 2020 census and using it to draw new congressional districts. The process has major implications for midterms, as Republicans could retake the majority just by gerrymandering enough seats into their column. In Maryland, state level Democrats are considering several maps, one of which would completely draw out the only Republican from the state in Congress.
Bruce DePuyt, senior reporter at Maryland Matters, and Helen Brewer, legal analyst at Princeton's Electoral Innovation Lab, join Cheddar Politics to discuss.
Today is Veterans Day, a day each year that gives us a chance to honor our service members and reflect on the issues they face in our armed forces. One issue that's gotten a lot of scrutiny recently is the handling of sexual assault cases in the military. The military has long been criticized for how it handles cases of sexual assault, with particular attention paid to how cases are investigated and prosecuted usually within the chain of command. The defense department has said sexual assault cases will be removed, but it's not the same as Congress changing the law itself.
Lory Manning, retired U.S. Navy captain and the director of government operations at the Service Women's Action Network, joins Cheddar News to discuss.
Greenwood, a digital banking platform aimed at supporting Black and Latino businesses and clients, is launching its very own GreenBook. Named after the historic publication for Black travelers during the era of Jim Crow, the online guide will provide a directory of Black- and Latino-owned businesses across the country. Ryan Glover, the founder and chairman of Greenwood, joined Cheddar to provide additional details about the listings.
President Biden's infrastructure plan will be pumping billions of dollars into the EV sector. David Shepardson, Correspondent at Thomson Reuters, joined Cheddar News' Closing Bell to break down all of the details.
Al Root, Senior Writer at Barron's, joined Wake Up With Cheddar's Jill Wagner to break down who qualifies for the proposed EV tax credits and why some automakers aren't too pleased about extra incentives for vehicles made at union plants.
Jill Wagner is joined by Baker to talk about kids and vaccines: we finally know how many young kids are getting vaccinated. Plus, Democrats are working on a Plan B for paid family leave. And the salad chain Sweetgreen goes public.
A breakthrough deal between the U.S. and China when it comes to climate has finally been reached. The two countries have pledged to work together to curb carbon emissions. Amy Harder, executive editor at Cipher, joined Cheddar News to discuss more.
President Joe Biden is expected to visit GM's 'Factory Zero' plant in Detroit, where mass production of its electric vehicle fleet will get underway. Biden is likely to tout his recently passed $1.2 trillion infrastructure plan, which allocates $7.5 billion toward EV infrastructure.
